Cargando…
Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients
BACKGROUND: Gender-based differences in disease onset in murine models of malignant peripheral nerve sheath tumor (MPNST) and in patients with Neurofibromatosis type-1-(NF-1)-associated or spontaneous MPNST has not been well studied. METHODS: Forty-three mGFAP-Cre+;Pten(loxp/+);LSL-K-ras(G12D/+) mic...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237782/ https://www.ncbi.nlm.nih.gov/pubmed/25398666 http://dx.doi.org/10.1186/1471-2407-14-827 |
_version_ | 1782345394537103360 |
---|---|
author | Shurell, Elizabeth Tran, Linh M Nakashima, Jonathan Smith, Kathleen B Tam, Brenna M Li, Yunfeng Dry, Sarah M Federman, Noah Tap, William D Wu, Hong Eilber, Fritz C |
author_facet | Shurell, Elizabeth Tran, Linh M Nakashima, Jonathan Smith, Kathleen B Tam, Brenna M Li, Yunfeng Dry, Sarah M Federman, Noah Tap, William D Wu, Hong Eilber, Fritz C |
author_sort | Shurell, Elizabeth |
collection | PubMed |
description | BACKGROUND: Gender-based differences in disease onset in murine models of malignant peripheral nerve sheath tumor (MPNST) and in patients with Neurofibromatosis type-1-(NF-1)-associated or spontaneous MPNST has not been well studied. METHODS: Forty-three mGFAP-Cre+;Pten(loxp/+);LSL-K-ras(G12D/+) mice were observed for tumor development and evaluated for gender disparity in age of MPNST onset. Patient data from the prospectively collected UCLA sarcoma database (1974–2011, n = 113 MPNST patients) and 39 published studies on MPNST patients (n = 916) were analyzed for age of onset differences between sexes and between NF-1 and spontaneous MPNST patients. RESULTS: Our murine model showed gender-based differences in MPNST onset, with males developing MPNST significantly earlier than females (142 vs. 162 days, p = 0.015). In the UCLA patient population, males also developed MPNST earlier than females (median age 35 vs. 39.5 years, p = 0.048). Patients with NF-1-associated MPNST had significantly earlier age of onset compared to spontaneous MPNST (median age 33 vs. 39 years, p = 0.007). However, expanded analysis of 916 published MPNST cases revealed no significant age difference in MPNST onset between males and females. Similar to the UCLA dataset, patients with NF-1 developed MPNST at a significantly younger age than spontaneous MPNST patients (p < 0.0001, median age 28 vs. 41 years) and this disparity was maintained across North American, European, and Asian populations. CONCLUSIONS: Although our preclinical model and single-institution patient cohort show gender dimorphism in MPNST onset, no significant gender disparity was detected in the larger MPNST patient meta-dataset. NF-1 patients develop MPNST 13 years earlier than patients with spontaneous MPNST, with little geographical variance. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2407-14-827) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4237782 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42377822014-11-21 Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients Shurell, Elizabeth Tran, Linh M Nakashima, Jonathan Smith, Kathleen B Tam, Brenna M Li, Yunfeng Dry, Sarah M Federman, Noah Tap, William D Wu, Hong Eilber, Fritz C BMC Cancer Research Article BACKGROUND: Gender-based differences in disease onset in murine models of malignant peripheral nerve sheath tumor (MPNST) and in patients with Neurofibromatosis type-1-(NF-1)-associated or spontaneous MPNST has not been well studied. METHODS: Forty-three mGFAP-Cre+;Pten(loxp/+);LSL-K-ras(G12D/+) mice were observed for tumor development and evaluated for gender disparity in age of MPNST onset. Patient data from the prospectively collected UCLA sarcoma database (1974–2011, n = 113 MPNST patients) and 39 published studies on MPNST patients (n = 916) were analyzed for age of onset differences between sexes and between NF-1 and spontaneous MPNST patients. RESULTS: Our murine model showed gender-based differences in MPNST onset, with males developing MPNST significantly earlier than females (142 vs. 162 days, p = 0.015). In the UCLA patient population, males also developed MPNST earlier than females (median age 35 vs. 39.5 years, p = 0.048). Patients with NF-1-associated MPNST had significantly earlier age of onset compared to spontaneous MPNST (median age 33 vs. 39 years, p = 0.007). However, expanded analysis of 916 published MPNST cases revealed no significant age difference in MPNST onset between males and females. Similar to the UCLA dataset, patients with NF-1 developed MPNST at a significantly younger age than spontaneous MPNST patients (p < 0.0001, median age 28 vs. 41 years) and this disparity was maintained across North American, European, and Asian populations. CONCLUSIONS: Although our preclinical model and single-institution patient cohort show gender dimorphism in MPNST onset, no significant gender disparity was detected in the larger MPNST patient meta-dataset. NF-1 patients develop MPNST 13 years earlier than patients with spontaneous MPNST, with little geographical variance. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2407-14-827) contains supplementary material, which is available to authorized users. BioMed Central 2014-11-15 /pmc/articles/PMC4237782/ /pubmed/25398666 http://dx.doi.org/10.1186/1471-2407-14-827 Text en © Shurell et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Research Article Shurell, Elizabeth Tran, Linh M Nakashima, Jonathan Smith, Kathleen B Tam, Brenna M Li, Yunfeng Dry, Sarah M Federman, Noah Tap, William D Wu, Hong Eilber, Fritz C Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients |
title | Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients |
title_full | Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients |
title_fullStr | Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients |
title_full_unstemmed | Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients |
title_short | Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients |
title_sort | gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237782/ https://www.ncbi.nlm.nih.gov/pubmed/25398666 http://dx.doi.org/10.1186/1471-2407-14-827 |
work_keys_str_mv | AT shurellelizabeth genderdimorphismandageofonsetinmalignantperipheralnervesheathtumorpreclinicalmodelsandhumanpatients AT tranlinhm genderdimorphismandageofonsetinmalignantperipheralnervesheathtumorpreclinicalmodelsandhumanpatients AT nakashimajonathan genderdimorphismandageofonsetinmalignantperipheralnervesheathtumorpreclinicalmodelsandhumanpatients AT smithkathleenb genderdimorphismandageofonsetinmalignantperipheralnervesheathtumorpreclinicalmodelsandhumanpatients AT tambrennam genderdimorphismandageofonsetinmalignantperipheralnervesheathtumorpreclinicalmodelsandhumanpatients AT liyunfeng genderdimorphismandageofonsetinmalignantperipheralnervesheathtumorpreclinicalmodelsandhumanpatients AT drysarahm genderdimorphismandageofonsetinmalignantperipheralnervesheathtumorpreclinicalmodelsandhumanpatients AT federmannoah genderdimorphismandageofonsetinmalignantperipheralnervesheathtumorpreclinicalmodelsandhumanpatients AT tapwilliamd genderdimorphismandageofonsetinmalignantperipheralnervesheathtumorpreclinicalmodelsandhumanpatients AT wuhong genderdimorphismandageofonsetinmalignantperipheralnervesheathtumorpreclinicalmodelsandhumanpatients AT eilberfritzc genderdimorphismandageofonsetinmalignantperipheralnervesheathtumorpreclinicalmodelsandhumanpatients |